Stabilised.
Our formulation protects delicate EPA and DHA against oxidation and addresses their inherent instability.
Advanced skincare
A fresh direction
for skin.
Algae-derived EPA + DHA.
Stabilised. Formulated for skin.
Difficult ingredients.
New possibilities
for skin.
The potential of algae-derived EPA and DHA has come with difficult formulation barriers: oxidation, instability and sticky handling.
We have overcome those barriers together. Our formulation stabilises these delicate lipids, makes them practical to work with and brings them into a delivery system evaluated in human skin tissue.
Explore the breakthroughMore than an
ingredient story.
EPA + DHA.
The formulation makes the difference.
Made workable.
We resolve the sticky, difficult handling that makes these lipids challenging to use in skincare.
Delivery evaluated.
An external human-skin tissue study observed tagged encapsulated material within the epidermis.
From a difficult ingredient
to a daily ritual.
Advanced formulation.
Everyday skincare.
The science behind
something personal.
We shape this formulation around your product vision—from the experience you want to create to the requirements of your production line.
Shape your skincare applicationSkin delivery,
demonstrated.
Ex vivo human-skin study.
Evaluated by Denova Sciences.
Inside the epidermis.
Wintershine Health & Skincare
Orange · tagged materialBlue · cell nucleiScale bars: 100 µm
24h
Observation time
Ex vivo human skin
Observed within the epidermis.
Fluorescence imaging located tagged encapsulated material within the skin’s epidermal layer at the first observation.
Evaluated by Denova Sciences for Wintershine Health & Skincare.
Study notes & interpretation
Study: Denova Sciences evaluated two tagged encapsulation systems in human skin tissue for Wintershine Health & Skincare (report DS2026009).
Method: Formulations were applied to human skin tissue in Franz diffusion cells. Confocal fluorescence imaging assessed tagged material at 24 and 72 hours, alongside a PBS control.
Observation: Both systems showed tagged material within the epidermis at 24 hours, with signal also detected at 72 hours. The viewer shows unchanged panels from Figure 2 for one system and its PBS control. Scale bars represent 100 µm.
Readout: Fluorescence shows the location of tagged material at the two observation times. This is a skin-tissue delivery evaluation, rather than a measurement of EPA/DHA dose or clinical skin benefits.
Why partner with us?
We create and validate
We develop breakthrough formulations and validate the results that matter to your business.
We support production
We optimise formulations for your production needs and support your team through scale-up.
We supply key ingredients
We supply hard-to-produce ingredients that make your formulation possible, so you can focus on your business.
We keep refining
We refine formulations over time, sharing updates and improved ingredients as your needs evolve.
An existing formulation or a new challenge.
Let’s explore what comes next.
A few practical
questions.
What has already been developed?
Our algae-derived EPA and DHA formulation addresses oxidation, stability and difficult ingredient handling. Its encapsulation systems have also been evaluated for delivery in an external ex vivo human-skin study. We can build from this developed formulation around your product requirements.
Can we build on this formulation?
Yes. We start with the skincare product you want to create, its intended experience and your production requirements. Together, we assess formulation fit and the evaluation needed for that application.
What does the skin-delivery study show?
Tagged encapsulated material was observed within the epidermis at 24 hours and was also detected at the 72-hour observation. Denova Sciences carried out the evaluation in human skin tissue for Wintershine Health & Skincare. The original microscopy is shown above.
How would we evaluate it for our product?
We agree on the properties and outcomes that matter to your product. Stability, handling, delivery and any intended product claims shape the testing programme.
What do you need for a first conversation?
Share the skincare application, the ingredient or formulation challenge, and the improvement you want to achieve. A high-level brief is enough to begin; production support, key ingredient supply and ongoing refinement can be shaped together.
